| Date Filed | Type | Description |
| 05/24/2023 |
4
| Hatfield Jeffrey S. (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Granted 6,027 shares
@ $0
Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2021 |
4
| Hatfield Jeffrey S. (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Granted 3,374 shares
@ $0
Granted 6,748 options to buy
@ $45.28, valued at
$305.5k
|
|
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/11/2020 |
4
| Hatfield Jeffrey S. (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Granted 46,500 options to buy
@ $29.43, valued at
$1.4M
|
|
| 12/11/2020 |
3
| Hatfield Jeffrey S. (Director) has filed a Form 3 on Vir Biotechnology, Inc. |
| 05/22/2020 |
4
| Hatfield Jeffrey S. (Director) has filed a Form 4 on MIRAGEN THERAPEUTICS, INC.|
Txns:
| Granted 24,000 options to buy
@ $0.6261, valued at
$15k
|
|
| 05/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2019 |
4
| Hatfield Jeffrey S. (Director) has filed a Form 4 on MIRAGEN THERAPEUTICS, INC.|
Txns:
| Granted 12,000 options to buy
@ $2.36, valued at
$28.3k
|
|
| 05/10/2019 |
4
| Hatfield Jeffrey S. (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 20,000 options to buy
@ $0.5834, valued at
$11.7k
|
|
| 01/24/2019 |
4
| Hatfield Jeffrey S. (CEO) has filed a Form 4 on ZAFGEN, INC.|
Txns:
| Granted 525,000 options to buy
@ $4.63, valued at
$2.4M
|
|
| 06/28/2018 |
4
| Hatfield Jeffrey S. (Director) has filed a Form 4 on MIRAGEN THERAPEUTICS, INC.|
Txns:
| Granted 12,000 options to buy
@ $6.46, valued at
$77.5k
|
|
| 05/17/2018 |
4
| Hatfield Jeffrey S. (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 20,000 options to buy
@ $1.35, valued at
$27k
|
|
| 02/23/2018 |
4
| Hatfield Jeffrey S. (CEO) has filed a Form 4 on ZAFGEN, INC.|
Txns:
| Granted 275,000 options to buy
@ $7.77, valued at
$2.1M
|
|
| 01/23/2018 |
4
| Hatfield Jeffrey S. (Director) has filed a Form 4 on INVIVO THERAPEUTICS HOLDINGS CORP.|
Txns:
| Granted 12,500 options to buy
@ $0.69, valued at
$8.6k
|
|
| 12/29/2017 |
4
| Hatfield Jeffrey S. (CEO) has filed a Form 4 on ZAFGEN, INC.|
Txns:
| Granted 1,100,000 options to buy
@ $3.4, valued at
$3.7M
|
|
| 10/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/11/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/11/2017 |
4
| Hatfield Jeffrey S. (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 20,000 options to buy
@ $3.15, valued at
$63k
|
|
| 04/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/04/2017 |
3
| Hatfield Jeffrey S. (Director) has filed a Form 3 on aTYR PHARMA INC |
| 11/03/2016 |
4
| Hatfield Jeffrey S. (Director) has filed a Form 4 on INVIVO THERAPEUTICS HOLDINGS CORP.|
Txns:
| Granted 25,000 options to buy
@ $4.25, valued at
$106.3k
|
|
| 11/03/2016 |
3
| Hatfield Jeffrey S. (Director) has filed a Form 3 on INVIVO THERAPEUTICS HOLDINGS CORP. |
| 10/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/16/2016 |
4
| Hatfield Jeffrey S. (CEO) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Sold 50,000 shares
@ $20.81, valued at
$1M
|
|
| 08/17/2016 |
4
| Hatfield Jeffrey S. (CEO) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Granted 747 shares
@ $6.11, valued at
$4.6k
Granted 60,000 options to buy
@ $8.79, valued at
$527.4k
|
|